Eculizumab as Salvage Treatment for Thrombotic Microangiopathy After Lung Transplantation

Documenti analoghi

• Outcomes of Early Thrombotic Microangiopathy in Renal Transplantation
  di: Girish K. Mour, et al.
  Pubblicazione: (2024)
• Genetic and Functional Evaluation of the Complement System in De Novo Thrombotic Microangiopathy After Transplantation: A Single‐Center Experience
  di: Adam Bregman, et al.
  Pubblicazione: (2025)
• What Happens to Frailty in the First Year After Lung Transplantation?
  di: Louise Mary Fuller, et al.
  Pubblicazione: (2024)
• Perioperative Bleeding Risk in Lung Transplantation After Previous Cardiothoracic Surgery
  di: Bryan Chow, et al.
  Pubblicazione: (2025)
• Sleep and Respiratory Parameters After Lung Transplantation in Adult Patients With Cystic Fibrosis
  di: Alexandros Kalkanis, et al.
  Pubblicazione: (2024)